Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-Interventional, Post-Authorisation Study to Assess Adverse Events and Drug Utilisation Among Chronic Kidney Disease Patients Treated With DYNEPO

NCT00664066 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT00664066
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00664066 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-Interventional, Post-Authorisation Study to Assess Adverse Events and Drug Utilisation Among Chronic Kidney Disease Patients Treated With DYNEPO
Lead sponsor
Shire
Phase
Observational
Overall status
Terminated
Start date
April 25, 2008
Completion date
July 30, 2008
Enrollment
3 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, kidney diseases, kidney failure, chronic, renal failure, chronic